Korean Journal of Family Medicine (가정의학회지)

The Korean Academy of Family Medicine (대한가정의학회)
권호 표지
DOI QR코드

DOI QR Code

Factors Related to Human Papilloma Virus Infection Rate in Women

일부 여성에서 인유두종 바이러스 감염률과 관련요인

Kim, Sung-Hee;Lee, Ka-Young;Park, Tae-Jin;Kim, Jun-Su;Kim, Yeun-Mi;O, Hea-Sook
김성희;이가영;박태진;김준수;김은미;오혜숙

  • Published : 20091200
⟨ Previous Next ⟩

Abstract

Background: It is not clear which demographic factors would be considered for human papillomavirus (HPV) infection in Korean women and how women understand the HPV infection. This study was conducted to find the factors related to HIV infection and the realities of follow-up tests and perception among women infected with HPV. Methods: The subjects were 2,113 women (median 41 years old) who received a Papanicolaou smear and a HPV DNA test at a health promotion center from March 2006 to October 2007. The follow-up rate and perception for HPV infection among women infected by HPV were surveyed using telephone. Results: Overall prevalence of HPV infection was 17.3% (N = 365). However, the prevalence of HPV infection among women younger than 30 years old reached 30.7% (17.6% for low-risk group of HPV, 13.1% for high-risk group of HPV). The odds for being infected with HPV was 3.2 (95% confidence interval, 2.0 to 5.2) among unmarried women younger than 30 years old compared to those at the ages of 30 years or older. Married women younger than 30 years were also 2.1-4.3 times more likely to be infected with low-risk group of HPV compared to those aged 30 years or older. Among those infected with HPV and answered to the survey (N = 282), 51.4% took irregular gynecologic follow-up and 66.2% did not have information for the need or importance of follow-up examination. Conclusion: The risk of being infected with HPV seems to be higher for unmarried women younger than 30 years old. Additionally, a standardized guideline should be provided to improve follow-up examination and knowledge about HPV infection.

연구배경: 자궁경부암의 위험요인으로 알려진 인유두종 바이러스 감염과 관련된 대상자의 일부 특성과 인유두종 바이러스연구배경: 자궁경부암의 위험요인으로 알려진 인유두종 바이러스 감염과 관련된 대상자의 일부 특성과 인유두종 바이러스 감염이 확인된 대상자의 추적검사 양상 및 인유두종 바이러스 감염에 대한 인식을 파악하고자 본 연구를 시행하였다. 방법: 2006년 3월부터 2007년 10월까지 일개 대학병원 종합검진센터에서 자궁경부 세포진 검사와 인유두종 바이러스 검사를 받은 2,113명 여성 검진자들의 부인과적 설문지 및 검사결과를 연구도구로 이용하였으며 인유두종 바이러스 감염 양성자 365명 중 282명(응답률 77.3%)에게 인유두종 바이러스 감염진단후 추적검사 여부 및 인유두종 바이러스 감염에 대한인지를 전화로 조사하였다. 결과: 전체 대상자에서 인유두종 바이러스 감염률은 17.4%였으며, 30세 미만 대상자에서는 30.7%의 감염률(저위험군 인유두종 바이러스 감염률 17.6%, 고위험군 감염률 13.1%)을 보였다. 30세 이상인 여성에 비하여 30세 미만인 미혼 여성에서 인유두종 바이러스 감염의 유병비는 3.2 (95% 신뢰구간, 2.0-5.2)이었고, 저위험군 인유두종 바이러스 감염 위험은 30세 미만인 기혼 여성에서도 2.1-4.3배 유의하게 높았다. 전화 설문조사에 응답해 준 대상자의 51.4%는 진단 이후 추적검사를 한번 시행하거나 시행하지 않았고, 이들 중 66.2%는 추적검사의 필요성 및 중요성을 인지하지 못하고 있었다. 결론: 인유두종 바이러스 감염률은 30대 미만의 미혼 여성에서 높은 것으로 보이며 인유두종 바이러스 감염이 진단된 대상자들의 추적검사 및 이해를 증진하기 위한 표준화된 관리방안이 필요할 것으로 보인다.

Keywords

References

  1. Korea Central Cancer Registry. Records of Korea Central Cancer Registry, from 1999 to 2002. Goyang: National Cancer Center; 2007
  2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shan KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9 https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  3. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81-6 https://doi.org/10.1001/jama.283.1.81
  4. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37 https://doi.org/10.1097/00006250-199203000-00002
  5. Lee MY, Cho CH, Kwon SH, Song DK, Chung SW, Kang HO, et al. Annual report of gynecologic cancer registry program in Korea for 2002 (Jan. 1st, 2002 - Dec. 31st, 2002). Korean J Obstet Gynecol 2004;47:1029-70
  6. McCrory DC, Matchar DB, Bastian L, Datta S, Hasselblad V, Hickey J, et al. Evaluation of cervical cytology: evidence report/technology assessment No. 5. (prepared by Duke University under contract No. 290-97-0014.) AHCPR Publication No. 99-E010 [Internet]. Rockville (MD): Agency for Health Care Policy and Research; c1999 [cited 2002 Nov 25]. Available from: http://www.ahrq.gov/clinic/epcindex.htm
  7. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9 https://doi.org/10.1001/jama.287.16.2114
  8. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classifi cation of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27 https://doi.org/10.1056/NEJMoa021641
  9. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003;103:413-21 https://doi.org/10.1002/ijc.10825
  10. Kjellberg L, Wiklund F, Sjoberg I, Wadell G, Angstrom T, Dillner J, et al. A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia. Am J Obstet Gynecol 1998;179:1497-502 https://doi.org/10.1016/S0002-9378(98)70015-8
  11. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65 https://doi.org/10.1136/jcp.55.4.244
  12. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9 https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  13. Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24 Suppl 3:S52-61 https://doi.org/10.1016/j.vaccine.2006.05.031
  14. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005;32 Suppl 1:S7-15 https://doi.org/10.1016/j.jcv.2004.12.006
  15. Seo K. Human papillomavirus vaccine. Hanyang Med Rev 2008;28:64-9

Cited by

  1. 인유두종 바이러스와 관련된 낙인, 수치심과 검사의도의 영향요인 vol.42, pp.2, 2009, https://doi.org/10.4040/jkan.2012.42.2.217
  2. Recommended Managements for the Male Human Papillomavirus Infection vol.9, pp.2, 2009, https://doi.org/10.14777/kjutii.2014.9.2.79
  3. 성기사마귀환자 326명의 한의학적 치료에 대한 후향적 연구 vol.28, pp.4, 2009, https://doi.org/10.6114/jkood.2015.28.4.196
  4. 한국 성인여성의 인유두종 바이러스(HPV)백신 접종 및 접종의도에 영향을 미치는 요인: 체계적 문헌고찰 vol.32, pp.1, 2018, https://doi.org/10.5932/jkphn.2018.32.1.69